Cited by

• Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?

  Demirtürk N, Aygen B, Çelik İ, Mıstık R, Akhan S, Barut Ş, Ural O, Batırel A, Şimşek F, Ersöz G, İnan D, Kınıklı S, Türker N, Bilgin H, Gürbüz Y, Tülek N, Tarakçı H, Yıldız O, Türkoğlu E, Kamalak Güzel D, Şimşek S, Tuna N, Aktuğ Demir N, Çağatay A, Çetinkaya RA, Karakeçili F, Hakyemez İN, Tuncer Ertem G, Örmen B, Korkmaz P, Yıldız U, Kuruüzüm Z, Şener A, Arslan Özel S, Öztürk S, Suer K, Çelen MK, Konya P, Asan A, Saltoğlu N, Doğan N. Demirtürk N, et al. Turk J Gastroenterol. 2021 Feb;32(2):155-163. doi: 10.5152/tjg.2020.19569. Turk J Gastroenterol. 2021. PMID: 33960939 Free PMC article.
• Ultra-Deep Sequencing Characterization of HCV Samples with Equivocal Typing Results Determined with a Commercial Assay.

  Minosse C, Giombini E, Bartolini B, Capobianchi MR, Garbuglia AR. Minosse C, et al. Int J Mol Sci. 2016 Oct 7;17(10):1679. doi: 10.3390/ijms17101679. Int J Mol Sci. 2016. PMID: 27739414 Free PMC article.
• Managing HBV and HCV Infection Pre- and Post-liver Transplant.

  Kumar N, Choudhary NS. Kumar N, et al. J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101287. doi: 10.1016/j.jceh.2023.09.008. Epub 2023 Sep 23. J Clin Exp Hepatol. 2024. PMID: 38076445 Review.
• HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets.

  Carrasco T, Barquín D, Ndarabu A, Fernández-Alonso M, Rubio-Garrido M, Carlos S, Makonda B, Holguín Á, Reina G. Carrasco T, et al. Diagnostics (Basel). 2021 Mar 15;11(3):522. doi: 10.3390/diagnostics11030522. Diagnostics (Basel). 2021. PMID: 33804260 Free PMC article.
• Iberogast®-Induced Acute Liver Injury-A Case Report.

  Leroy A, Perrin H, Porret R, Sempoux C, Chtioui H, Fraga M, Bart PA. Leroy A, et al. Gastro Hep Adv. 2022 May 19;1(4):601-603. doi: 10.1016/j.gastha.2022.02.020. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39132058 Free PMC article.